Thereby, our study provides suggestive evidence that despite the use of large, multi-centric patient cohorts and powerful DL models, it is not possible to predict the mutational status of KRAS, NRAS, and PIK3CA from CRC histopathology slides with current methods. This evidence concerns the gene KRAS and colorectal carcinoma.